In-Person Access Only | 4.00 CE/CME Credits & MOC Points

For forty-six years, the San Antonio Breast Cancer Symposium’s mission has been to provide state-of-the-art information on breast cancer research.

The University of Kansas Cancer Center Breast Cancer Year in Review is a condensed review of the SABCS meeting held in December and it gives healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This accredited meeting is hosted as an in-person conference only with on-demand access for registered attendees.

Conference Agenda
Saturday, February 22, 2025

8:35 AM
Welcome and Exhibits

8:55 AM
Opening Remarks

9:00 AM
Non CME Presentation

9:45 AM
Neo-Adjuvant Systematic Therapy for HR+ Breast Cancer: Which Agents, When and for How Long?

10:10 AM
Genetic Testing and Management of Breast Cancer Susceptibility Germline Mutations

10:35 AM
Break and Exhibits

10:55 AM
Advanced Stage Hormone Positive Breast Cancer: Fine-Tuning Sequential Endocrine and Targeted Therapy

11:20 AM
Monday morning Ptacice Implications: Q&A and Case Discussion

12:05 PM
Break and Exhibits

12:15 PM
Non CME Presentation

1:00 PM
Antibody Drug Conjugates: Present and Future Applications in Breast Cancer

1:25 PM
Genetic Testing and Management of Breast Cancer Susceptibility Germline Mutations

1:50 PM
Break and Exhibits

2:00 PM
Neo and Adjuvent Therapy for Triple Negative Breast Cancer: Optimizing and Right-Sizing

2:25 PM
Monday morning Ptacice Implications: Q&A and Case Discussion

3:10 PM
Adjourn

Adgenda Subject To Change. All times are CST.

• Learning Objectives

  • Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various hematologic malignancies.

  • Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with hematologic malignancies.

  • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with hematologic malignancies.

• Accreditation Information | 4.00 CE/CME Credits

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of TBD ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 4.00 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program